Perbandingan Kadar Hemoglobin, Hematokrit, dan Leukosit Pasien Stroke Infark dan Stroke Perdarahan dengan Covid-19
DOI:
https://doi.org/10.29313/jrk.v4i2.5400Keywords:
Hemoglobin, Hematokrit, LeukositAbstract
Abstract. The highest number of stroke sufferers in 2018 were patients aged 75 years and over as much as 50.2% and the lowest was in the 15-24 year age range, which was equivalent to 0.6%. On the other hand, the Coronavirus disease-19 (COVID-19) pandemic has also recently attracted world attention. This study aims to determine the relationship between hemoglobin, hematocrit, and leukocytes with the incidence of stroke in Covid-19 patients at the Sumedang District Hospital in 2020-2022. The results of hemoglobin, hematocrit and leukocyte examinations are obtained through laboratory examination and are classified into normal or abnormal levels, while the diagnosis of Covid-19 is based on antigen examination. From the research results, it was found that of the 68 samples, the majority of stroke patients with Covid-19 at Sumedang District Hospital in 2020-2022 having an age range of 50-74 years were 47 people (69%). The majority of stroke patients with Covid-19 at Sumedang District Hospital in 2020-2022 were men as much as 37 people (54%). The majority of stroke patients among Covid-19 patients at the Sumedang District Hospital in 2020-2022 had hemoglobin in the range of 12.3-15.3 g/dl, hematocrit levels between 35-47%, and leukocyte levels >10,000 mm3. There is no relationship between hemoglobin, hematocrit and leukocyte levels with the incidence of stroke in Covid-19 patients at Sumedang District Hospital in 2020-2022.
Abstrak. Jumlah penderita stroke terbanyak pada tahun 2018 adalah pasien berusia 75 tahun keatas yaitu sebanyak 50,2% dan terendah pada rentang umur 15-24 tahun yaitu setara dengan 0,6%. Di sisi lain, pandemi Coronavirus disease- 19 (COVID-19) juga baru-baru ini menarik perhatian dunia. Penelitian ini bertujuan untuk mengetahui hubungan hemoglobin, hematokrit, dan leukosit dengan kejadian stroke pada pasien Covid-19 di RSUD Kabupaten Sumedang tahun 2020-2022. Penelitian ini menggunakan metode analitik observasional dengan desain cross sectional. Jumlah sample yang diambil sebanyak 68 orang. Dari hasil penelitian didapatkan bahwa dari 68 sampel, pasien stroke dengan Covid-19 di RSUD Sumedang pada tahun 2020-2022 memiliki rentang usia 50-74 tahun yaitu sebanyak 47 orang (69%). Sebagian besar pasien pasien stroke dengan Covid-19 di RSUD Sumedang pada tahun 2020-2022 adalah laki-laki yaitu sebanyak 37 orang (54%). Sebagian besar pasien stroke pada pasien Covid-19 di RSUD Kabupaten Sumedang tahun 2020-2022 memiliki hemoglobin di rentang 12.3-15.3 g/dl, kadar hematokrit antara 35-47%, dan kadar leukosit >10.000 mm3. Tidak terdapat perbandingan yang signifikan pada kadar hemoglobin, hematokrit, maupun leukosit dengan kejadian stroke pada pasien Covid-19 di RSUD Sumedang pada tahun 2020-2022.
References
Riset kesehatan dasar kementerian kesehatan republik indonesia tahun 2018.
Dhama K, Khan S, Tiwari R, Sircar S, Bhat S, Malik YS, et al. Coronavirus Disease 2019–COVID-19. Clin Microbiol Rev [Internet]. 2020 Sep 16;33(4). Available from: https://journals.asm.org/doi/10.1128/CMR.00028-20
Belani P, Schefflein J, Kihira S, Rigney B, Delman BN, Mahmoudi K, et al. COVID-19 Is an Independent Risk Factor for Acute Ischemic Stroke. American Journal of Neuroradiology. 2020 Aug;41(8):1361–4.
Khan M, Adil SF, Alkhathlan HZ, Tahir MN, Saif S, Khan M, et al. COVID-19: A Global Challenge with Old History, Epidemiology and Progress So Far. Molecules. 2020 Dec 23;26(1):39.
Keputusan menteri kesehatan republik indonesia nomor HK.01.07/MENKES/394/2019 tentang pedoman nasional pelayanan kedokteran tata laksana stroke.
Kuriakose D, Xiao Z. Pathophysiology and Treatment of Stroke: Present Status and Future Perspectives. Int J Mol Sci. 2020 Oct 15;21(20):7609.
Caplan LR. Caplan’s stroke : a clinical approach. Elsevier/Saunders; 2009. 656 p.
Keputusan menteri kesehatan republik indonesia keputusan menteri kesehatan republic indonesia nomor HK.01.07/MENKES/5671/2021 tentang manajemen klinis tata laksana corona virus disease 2019 (covid-19).
Azer SA. COVID-19: pathophysiology, diagnosis, complications and investigational therapeutics. New Microbes New Infect. 2020 Sep;37:100738.
Wolff D, Nee S, Hickey NS, Marschollek M. Risk factors for Covid-19 severity and fatality: a structured literature review. Infection. 2021 Feb 28;49(1):15–28.
Abu-Ismail L, Taha MJJ, Abuawwad MT, Al-Bustanji Y, Al-Shami K, Nashwan A, et al. COVID-19 and Anemia: What Do We Know So Far? Hemoglobin. 2023 May 4;47(3):122–9.
Kellert L, Martin E, Sykora M, Bauer H, Gussmann P, Diedler J, et al. Cerebral Oxygen Transport Failure?: Decreasing Hemoglobin and Hematocrit Levels After Ischemic Stroke Predict Poor Outcome and Mortality. Stroke. 2011 Oct;42(10):2832–7.
Grau M, Ibershoff L, Zacher J, Bros J, Tomschi F, Diebold KF, et al. Even patients with mild COVID‐19 symptoms after SARS‐CoV‐2 infection show prolonged altered red blood cell morphology and rheological parameters. J Cell Mol Med. 2022 May 13;26(10):3022–30.
Zhao K, Li R, Wu X, Zhao Y, Wang T, Zheng Z, et al. Clinical features in 52 patients with COVID-19 who have increased leukocyte count: a retrospective analysis. European Journal of Clinical Microbiology & Infectious Diseases. 2020 Dec 10;39(12):2279–87.
Integrasi Kesehatan J, Tursina A, Rahmat Putra A. ARTIKEL PENELITIAN Hubungan Letak Lesi Strok Iskemik dengan Kualitas Tidur di RSAU dr. M. Salamun Bandung.
Cerón Blanco N, Romero Hernández CA, Vallejo Fernández J. Acute stroke in COVID-19 patients: A first year experience in a Colombian hospital. Neurology Perspectives. 2023 Apr 1;3(2).
Triyani Y, Herawati R, Rahmawati R, Permatasari R. Impact of the COVID-19 Pandemic on Laboratory Services. Global Medical & Health Communication (GMHC). 2023 Dec 23;11(3).
Renita Sanyasi RDL, Ardi Pramudita E. Ischemic stroke in coronavirus disease 19 (COVID-19) positive patient: a case report. Journal of thee Medical Sciences (Berkala Ilmu Kedokteran). 2020 Jul 15;52(03).
Nader E, Nougier C, Boisson C, Poutrel S, Catella J, Martin F, et al. Increased blood viscosity and red blood cell aggregation in patients with COVID-19. Am J Hematol. 2022 Mar 1;97(3):283–92.
Rasyid, A. (2021). Peran parameter hemoreologi dan hemostasis sebagai faktor prognosis stroke iskemik akut dengan covid-19. Neurona, 38(4)
Sato F, Nakamura Y, Kayaba K, Ishikawa S. Hemoglobin Concentration and the Incidence of Stroke in the General Japanese Population: The Jichi Medical School Cohort Study. J Epidemiol. 2022;32(3):125–30.
Ekayanti MS, Fandy Bachtiar M, Kembuan MAHN, Runtuwene T, Tumboimbela J. Hematocrit level in stroke acute in the neurological department of national hospital prof. Dr. R. D. Kandou manado period may 2013 until may 2015. Vol. 1, Jurnal Sinaps. 2018.
Rachmani Mira Hamzah S. “Leukocytes count in the ischemic and hemorrhagic stroke patient.” Vol. 4, Leukocytes Count In The Ischemic And Hemorrhagic Stroke Patient J MAJORITY |. 2015.
Wang A, Quan K, Tian X, Zuo Y, Meng X, Chen P, et al. Leukocyte subtypes and adverse clinical outcomes in patients with acute ischemic cerebrovascular events. Ann Transl Med. 2021 May;9(9):748–748.
Quan K, Wang A, Zhang X, Wang Y. Leukocyte Count and Adverse Clinical Outcomes in Acute Ischemic Stroke Patients. Front Neurol. 2019 Nov 26;10.
Hidayat, R., Fathi, G. C., Zairinal, R. A., Handayani, R. R. D., Kurniawan, M., Rasyid, A., Haris, S., & Mesiano, T. (2021). Kejadian stroke iskemik pada pasien positif covid-19 terkonfirmasi di rumah sakit universitas indonesia. Neurona, 38(2), 148-154.
Yulianti Bisri D. Korelasi antara Stroke dengan Covid-19. Jurnal Neuroanestesi Indonesia. 2021 Jun 26;10(2):133–43.
Priyanto Hamidjoyo B, Riyanto Wreksoatmodjo B (2021). Terhadap Insidens dan Tatalaksana Penyakit Serebrovaskular. Vol. 48, CDK Edisi CME-3
